Thalidomide in Treating Patients With Gynecologic Sarcomas

ClinicalTrials.gov ID: NCT00006005

Public ClinicalTrials.gov record NCT00006005. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 5, 2026, 3:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Thalidomide (NSC #66847) in Patients With Sarcomas of Gynecologic Origin

Study identification

NCT ID: NCT00006005
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: New York University Cancer Institute; Other
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

thalidomide Drug

Drug

Eligibility (public fields only)

Age range: Not listed
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 31, 2000
Primary completion: Not listed
Completion: Jul 31, 2006
Last update posted: Jun 20, 2013

2000 – 2006

United States locations

U.S. sites: 10
U.S. states: 2
U.S. cities: 6

Facility	City	State	ZIP	Site status
Cancer Center of Albany Medical Center	Albany	New York	12208	—
North Shore University Hospital	Manhasset	New York	11030	—
St. Vincent's Comprehensive Cancer Center	New York	New York	10011	—
NYU School of Medicine's Kaplan Comprehensive Cancer Center	New York	New York	10016	—
St. Luke's-Roosevelt Hospital Center - Roosevelt Division	New York	New York	10019	—
New York Weill Cornell Cancer Center at Cornell University	New York	New York	10021	—
Mount Sinai School of Medicine	New York	New York	10029	—
Albert Einstein Clinical Cancer Center	The Bronx	New York	10461	—
New York Medical College	Valhalla	New York	10595	—
University of Wisconsin Comprehensive Cancer Center	Madison	Wisconsin	53792-6164	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00006005, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 20, 2013 · Synced May 5, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006005 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →